Efficacy of nonavalent human papillomavirus vaccine for recalcitrant warts

Ital J Dermatol Venerol. 2023 Feb;158(1):67-68. doi: 10.23736/S2784-8671.22.07380-7.

Authors

Caterina Dianzani¹, Nicoleta Neagu², Aldo Venuti³, Giulia Coscarella¹, Benedetta DE Franciscis¹, Francesco Montini¹, Iris Zalaudek⁴, Claudio Conforti⁴

Affiliations

¹ Unit of Plastic and Reconstructive Surgery, Campus Bio-Medico University, Rome, Italy.
² Department of Epidemiology, George Emil Palade University of Medicine, Pharmacy, Science and Technology, Târgu Mureș, Romania - neagunicoleta92@yahoo.com.
³ HPV-Unit, UOSD Tumor Immunology and Immunotherapy, IRCCS Regina Elena National Cancer Institute, Rome, Italy.
⁴ Department of Dermatology, Maggiore Hospital, University of Trieste, Trieste, Italy.

PMID: 36939508
DOI: 10.23736/S2784-8671.22.07380-7

No abstract available

MeSH terms

Human Papillomavirus Viruses
Humans
Papillomavirus Infections* / prevention & control
Papillomavirus Vaccines* / therapeutic use
Warts* / therapy

Substances

Papillomavirus Vaccines